December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Elevated IL-6 Levels in the Vitreous of Patients With Active Posterior Uveitis
Author Affiliations & Notes
  • GN Papaliodis
    Uveitis/Immunology Mass Eye & Ear Infirmary Boston MA
  • VL Perez
    Uveitis / Immunology Massachusetts Eye and Ear Infirmary Boston MA
  • C Foster
    Uveitis / Immunology Massachusetts Eye and Ear Infirmary Boston MA
  • Footnotes
    Commercial Relationships   G.N. Papaliodis, None; V.L. Perez, None; C. Foster, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 4248. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      GN Papaliodis, VL Perez, C Foster; Elevated IL-6 Levels in the Vitreous of Patients With Active Posterior Uveitis . Invest. Ophthalmol. Vis. Sci. 2002;43(13):4248.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To measure the levels of selected inflammatory cytokines in vitreous samples obtained in patients with active posterior uveitis. Methods: Vitreous samples were obtained from 21 patients (23 eyes) with active posterior uveitis who underwent diagnostic or therapeutic pars plana vitrectomy. Undiluted vitreous was stored at -80 F until assay. Samples were thawed and IL-1a, IL-1b, IL-2, IL-6, TNF alpha levels were measured by Elisa using commercial kits (Endogen). Undiluted vitreous from 6/23 samples was stained for T and B cell markers (CD3, CD4, CD8, CD45, CD20) and analyzed by flow cytometry (Beckton-Dickinson). Results: There was no measurable IL-1a, IL1-b, IL-2, or TNF alpha in the vitreous samples. IL-6 was the only cytokine elevated in 44% (10/23) of the samples tested. We found no correlation between diagnosis and the presence of IL-6. However, patients with CNS lymphoma had no detectable IL-6 levels present in the vitreous (2/23 samples). Although flow ctometry was not performed on all samples, the limited number of assayed vitreous was consistent with the presence of mostly T cells with mixed CD4 and CD8 phenotype. Conclusion: IL-6 is detectable in vitreous from patients with active intraocular inflammation. These results are consistent with an animal model of induced uveitis in which elevated levels of IL-6 abolish immune privilege. IL-1a, IL-1b, IL-2, or TNF alpha were not detected and hence may not play a significant role in posterior uveitis.

Keywords: 380 cytokines/chemokines • 629 vitreous • 437 inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×